These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 32439428

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
    Hamilton BE, Nesbit GM, Dosa E, Gahramanov S, Rooney B, Nesbit EG, Raines J, Neuwelt EA.
    AJR Am J Roentgenol; 2011 Oct; 197(4):981-8. PubMed ID: 21940589
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ferumoxytol negatively enhances T2 -weighted MRI of pedal osteomyelitis in vivo.
    Neuwelt A, Langsjoen J, Byrd T, Eberhardt S, Mlady G, Baca J, Bocklage T, Martinez C, Orner J, Rivera M, Sillerud LO.
    J Magn Reson Imaging; 2017 Apr; 45(4):1241-1245. PubMed ID: 27654009
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.
    Siedek F, Muehe AM, Theruvath AJ, Avedian R, Pribnow A, Spunt SL, Liang T, Farrell C, Daldrup-Link HE.
    Eur Radiol; 2020 Mar; 30(3):1790-1803. PubMed ID: 31844962
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S, Raslan AM, Muldoon LL, Hamilton BE, Rooney WD, Varallyay CG, Njus JM, Haluska M, Neuwelt EA.
    Int J Radiat Oncol Biol Phys; 2011 Feb 01; 79(2):514-23. PubMed ID: 20395065
    [Abstract] [Full Text] [Related]

  • 9. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA, Várallyay CG, Manninger S, Solymosi D, Haluska M, Hunt MA, Nesbit G, Stevens A, Jerosch-Herold M, Jacobs PM, Hoffman JM.
    Neurosurgery; 2007 Apr 01; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3.0 T.
    Colbert CM, Ming Z, Pogosyan A, Finn JP, Nguyen KL.
    J Magn Reson Imaging; 2023 Jun 01; 57(6):1819-1829. PubMed ID: 36250695
    [Abstract] [Full Text] [Related]

  • 12. Macrophage activity in infected areas of an experimental vertebral osteomyelitis model: USPIO-enhanced MR imaging--feasibility study.
    Bierry G, Jehl F, Boehm N, Robert P, Prévost G, Dietemann JL, Desal H, Kremer S.
    Radiology; 2008 Jul 01; 248(1):114-23. PubMed ID: 18458246
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.
    Hamilton BE, Barajas R, Nesbit GM, Fu R, Ambady P, Taylor M, Neuwelt EA.
    AJR Am J Roentgenol; 2020 Dec 01; 215(6):1436-1442. PubMed ID: 33052739
    [Abstract] [Full Text] [Related]

  • 15. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
    Simon GH, Raatschen HJ, Wendland MF, von Vopelius-Feldt J, Fu Y, Chen MH, Daldrup-Link HE.
    Acad Radiol; 2005 Sep 01; 12(9):1190-7. PubMed ID: 16099684
    [Abstract] [Full Text] [Related]

  • 16. Emerging applications for ferumoxytol as a contrast agent in MRI.
    Bashir MR, Bhatti L, Marin D, Nelson RC.
    J Magn Reson Imaging; 2015 Apr 01; 41(4):884-98. PubMed ID: 24974785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E, Cariello G, Barile A, Sabatini M, Michelini O, Erriquez D, Masciocchi C.
    Radiol Med; 2000 Oct 01; 100(4):245-50. PubMed ID: 11155451
    [Abstract] [Full Text] [Related]

  • 20. Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.
    Varallyay CG, Nesbit E, Horvath A, Varallyay P, Fu R, Gahramanov S, Muldoon LL, Li X, Rooney WD, Neuwelt EA.
    J Magn Reson Imaging; 2018 Aug 01; 48(2):441-448. PubMed ID: 29314418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.